Negative v positive schizophrenia. Definition and validation.
about
A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut LodgeIncreased baseline occupancy of D2 receptors by dopamine in schizophreniaNeuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity.Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Dysfunctional Activation of the Cerebellum in Schizophrenia: A Functional Neuroimaging Meta-AnalysisErythropoietin: a candidate compound for neuroprotection in schizophreniaDUF1220 copy number is associated with schizophrenia risk and severity: implications for understanding autism and schizophrenia as related diseasesConverting positive and negative symptom scores between PANSS and SAPS/SANSThe current conceptualization of negative symptoms in schizophreniaAnhedonia in schizophrenia: a review of assessment strategiesProgressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine.Magnetic resonance spectroscopic determination of a neuronal and axonal marker in white matter predicts reversibility of deficits in secondary normal pressure hydrocephalusAuditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset.Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophreniaCerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity.Moderating factors for the effectiveness of group art therapy for schizophrenia: secondary analysis of data from the MATISSE randomised controlled trial.Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium.The MATISSE study: a randomised trial of group art therapy for people with schizophreniaUltrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Stereopsis deficits in patients with schizophrenia in a Han Chinese populationRelative food preference and hedonic judgments in schizophreniaTopographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.Verbal creativity and schizotypal personality in relation to prefrontal hemispheric laterality: a behavioral and near-infrared optical imaging study.Eye tracking in normals: spem asymmetries and association with schizotypy.Negative symptoms in schizophrenia: avolition and Occam's razorAn MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia.Irony and proverb comprehension in schizophrenia: do female patients "dislike" ironic remarks?Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification testGyrification and neural connectivity in schizophrenia.Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia.Reviewing the Dissociative Symptoms in Patients With Schizophreniaand their Association With Positive and Negative Symptoms.Improving prefrontal cortex function in schizophrenia through focused training of cognitive controlPerception of biological motion in schizophrenia and healthy individuals: a behavioral and FMRI study.Negative symptoms: psychopathological modelsThe dimensional approach to clinical psychopharmacology: a polysemous concept.
P2860
Q24534021-69CA81B3-0AD8-47E7-B561-B91C80E44150Q24616511-6E40C7D6-5E98-4B11-A875-15733D89EFF6Q24644123-FDAD0B41-5A63-41F4-9247-0CE87C3F408EQ24676113-4F106CC0-B128-4A80-9697-49E69603357EQ24812993-1C4253B6-FB66-4A88-B19B-A1600B13A328Q26774767-84568DB0-38AE-45D3-8D32-4F51B2A666BEQ27001119-D9BA7790-8129-426E-94E6-1A4299EBEBDAQ27322099-75D5F035-3D5D-4256-B0AC-3764F28B380EQ28212816-04FC0CB8-6851-49BC-A60D-F2441013CF35Q28271073-BE587769-2D0D-400C-A6BA-08E3F078DA9AQ28660667-9B143618-7DD1-454C-97A7-542F5F802905Q30364829-43989F93-60F6-4A7D-AFA8-D49F6F102522Q30491345-FC5032A8-FE20-466C-BB15-B3E515A10FDFQ30491416-9F205320-C76B-4CFC-9F13-FD67564DB12BQ30495447-B4097620-BFDC-4B02-8D28-640062D53844Q30540324-50EEE77D-4B85-4D2B-84BC-71C8C6F7FE0EQ30575242-96261F18-5F79-49FC-91EA-3F8F388A9416Q30584569-D6A142B1-B833-48CE-92D5-C2F1007B4A1EQ30798675-53696FDD-5BB9-4C67-A3D6-980FEC38D326Q30839102-22D94E04-2FE9-49B3-8779-D0F637E1E823Q30988171-7B883467-E944-4792-ABAA-ABAAE43D5D43Q31165044-65F686A3-6689-42E9-A893-9E84D154A097Q33223628-F70DDD82-07C6-4AF6-AA42-AE0F14F12FAAQ33257886-995575AD-21A8-432C-87D5-ABB80960DC3CQ33555434-132E73CF-9132-4771-9E13-5E5BBD9ECB37Q33625296-64E379FC-517C-4BE1-85B7-CC27760BF199Q33630401-95F5D716-C0A4-4933-9141-16AF1A7DC151Q33635584-429AD6E0-DBED-4AE5-8D33-8157C0313747Q33680634-60110DFE-2928-4456-A886-A829076040D9Q33707635-21F14B53-BEBC-4534-9A07-2770E657BBB4Q33752071-AA07B5C6-6C69-42F8-AE87-1FE926ACFFBAQ33765366-91CFE0C6-FBBB-4517-B9A2-DBDADC85AD87Q33780995-5140F6CA-A290-4869-8B1B-76E4425EC48CQ33801763-598875A1-D2F8-4A0E-BEE8-6F17156CF6EAQ33824821-2ECD300F-13A5-4477-9818-0165DCB68E1FQ33834444-07054A24-56AD-46A1-A46E-FCA0785347F5Q33837365-203093EE-F371-4C1E-90C3-8C3495611F43Q33916365-975CBD23-4586-4436-A01D-13B70148C175Q33920833-8D44CD2A-983B-46C9-8E5F-B5830BD21703Q33921041-B8A59867-6CFC-4505-8117-69F79A21BED6
P2860
Negative v positive schizophrenia. Definition and validation.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Negative v positive schizophrenia. Definition and validation.
@en
Negative v positive schizophrenia. Definition and validation.
@nl
type
label
Negative v positive schizophrenia. Definition and validation.
@en
Negative v positive schizophrenia. Definition and validation.
@nl
prefLabel
Negative v positive schizophrenia. Definition and validation.
@en
Negative v positive schizophrenia. Definition and validation.
@nl
P1433
P1476
Negative v positive schizophrenia. Definition and validation.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1982.04290070025006
P407
P577
1982-07-01T00:00:00Z